You are here

  • Home
  • Archive
  • Volume 82, Issue 4
  • Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality?

Article info

Article menu
Download PDFPDF
Letter
Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality?

Authors

  • Marcus von Deimling Department of Rheumatology and Clinical Immunology, University of Freiburg Hospital Department of Internal Medicine, Freiburg im Breisgau, Germany PubMed articlesGoogle scholar articles
  • Thomas C Koehler Department of Pneumology, University of Freiburg Hospital Department of Internal Medicine, Freiburg im Breisgau, Germany PubMed articlesGoogle scholar articles
  • Bjoern Christian Frye Department of Pneumology, University of Freiburg Hospital Department of Internal Medicine, Freiburg im Breisgau, Germany PubMed articlesGoogle scholar articles
  • Elisabeth Maerker-Hermann Department of Rheumatology, Clinical Immunology and Nephrology, Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbH, Wiesbaden, Germany PubMed articlesGoogle scholar articles
  • Nils Venhoff Department of Rheumatology and Clinical Immunology, University of Freiburg Hospital Department of Internal Medicine, Freiburg im Breisgau, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nils Venhoff, Department of Rheumatology and Clinical Immunology, University of Freiburg Hospital Department of Internal Medicine, 79106 Freiburg im Breisgau, Baden-Württemberg, Germany; nils.venhoff{at}uniklinik-freiburg.de
View Full Text

Citation

von Deimling M, Koehler TC, Frye BC, et al
Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality?
Annals of the Rheumatic Diseases 2023;82:580-582.

Publication history

  • Received November 7, 2022
  • Accepted December 13, 2022
  • First published December 20, 2022.
Online issue publication 
March 10, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.